Core Viewpoint - The company demonstrates strong confidence in its intrinsic value and long-term development through frequent share buybacks, signaling positive financial health and operational capabilities [1][2]. Group 1: Share Buyback Activity - The company announced its 10th share buyback in December, repurchasing 190,000 shares at HKD 5.13 per share, totaling approximately HKD 1 million [1]. - Cumulatively, the company has repurchased 3.34 million shares in December, amounting to about HKD 17 million [1]. - Frequent and sustained buyback operations reflect the company's belief in its undervalued stock price and financial strength to support future strategic investments [2]. Group 2: Business Development and Industry Engagement - The company has joined the Health Sustainable Development Working Committee under the Shanghai Cooperation Organization's economic platform, enhancing its role in international healthcare collaboration [1]. - As the main operator of the "Beijing Universal Health Insurance" program, the company has surpassed 3 million insured participants, showcasing its strong operational capabilities in the public health insurance sector [1]. - The company has been elected as the deputy chairman unit of the Smart Healthcare Working Committee of the China Internet Association, further solidifying its industry influence and technological leadership [1]. Group 3: Financial Performance - The company reported steady revenue growth in its mid-term results for the fiscal year 2026, nearing breakeven [1]. - Significant improvement in key financial metrics is attributed to the continuous increase in gross margin of core business and enhanced operational efficiency [1]. - These financial indicators reflect the company's improved commercialization capabilities and substantial progress in operational quality [1].
医渡科技(02158)12月以来第10次回购 持续传递发展信心